[1]
R. G. Moore, E. Smith, Y. Armbuster, M. C. Miller, G. Messerlian, and A. Blackman, “A Novel Marker for the Management of Patients Diagnosed with Endometrial Adenocarcinoma of the Uterus: HE4 a novel serum marker for endometrial cancer”, Clin J Obstet Gynecol, pp. 001–007, Mar. 2026.